相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycemic Variability Should we and can we prevent it?
Louis Monnier et al.
DIABETES CARE (2008)
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes
J. -P. Courreges et al.
DIABETIC MEDICINE (2008)
Variability in the relationship between mean plasma glucose and HbAIc:: Implications for the assessment of glycemic control
Eric S. Kilpatrick et al.
CLINICAL CHEMISTRY (2007)
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes - A randomized trial
Bernard Zinman et al.
ANNALS OF INTERNAL MEDICINE (2007)
Exenatide - A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea)
Risto S. Cvetkovic et al.
DRUGS (2007)
Mathematical modeling shows exenatide improved β-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea
A. Mari et al.
HORMONE AND METABOLIC RESEARCH (2006)
Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus
Shinichiro Mine et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes
F Fehse et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes - A randomized trial
RJ Heine et al.
ANNALS OF INTERNAL MEDICINE (2005)
Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients
A Ceriello et al.
CIRCULATION (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells
S Dhindsa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Inflammation: the link between insulin resistance, obesity and diabetes
P Dandona et al.
TRENDS IN IMMUNOLOGY (2004)
C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance
KCB Tan et al.
DIABETES CARE (2003)
C-reactive protein and glycemic control in adults with diabetes
DE King et al.
DIABETES CARE (2003)
Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ
P Trayhurn et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2001)
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
LJ Roberts et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
分享论文
